These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18939637)

  • 1. Protective efficacy of commercial Newcastle disease vaccines against challenge of goose origin virulent Newcastle disease virus in geese.
    Dai Y; Liu M; Li W
    Avian Dis; 2008 Sep; 52(3):467-71. PubMed ID: 18939637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of domestic geese to lentogenic and velogenic strains of Newcastle disease virus.
    Bolte AL; Voss M; Vielitz E; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):155-9. PubMed ID: 11370475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
    Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaccination with La Sota strain vaccine to control Newcastle disease in village chickens in Nepal.
    Shrestha S; Dhawan M; Donadeu M; Dungu B
    Trop Anim Health Prod; 2017 Feb; 49(2):439-444. PubMed ID: 27987111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic variation between Newcastle disease viruses of goose and chicken origin.
    Li ZJ; Li Y; Chang S; Ding Z; Mu LZ; Cong YL
    Arch Virol; 2010 Apr; 155(4):499-505. PubMed ID: 20204429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.
    Folitse R; Halvorson DA; Sivanandan V
    Avian Dis; 1998; 42(1):173-8. PubMed ID: 9533096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and evaluation of a recombinant goose origin Newcastle disease virus expressing Cap protein of goose origin avastrovirus as a bivalent vaccine in goslings.
    Xu D; Li C; Liu G; Chen Z; Jia R
    Poult Sci; 2019 Oct; 98(10):4426-4432. PubMed ID: 31111922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
    Wajid A; Basharat A; Bibi T; Rehmani SF
    Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of the immunoenhancement potential of Newcastle disease vaccine formulated as a cationic liposome.
    Onuigbo EB; Okore VC; Ofokansi KC; Okoye JO; Nworu CS; Esimone CO; Attama AA
    Avian Pathol; 2012; 41(4):355-60. PubMed ID: 22834549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs.
    Hu Z; Hu S; Meng C; Wang X; Zhu J; Liu X
    Avian Dis; 2011 Sep; 55(3):391-7. PubMed ID: 22017036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.